|
Volumn 65, Issue 1, 2001, Pages 26-40
|
Treatment-resistant bipolar disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
CLOZAPINE;
FLUPENTIXOL;
GABAPENTIN;
LAMOTRIGINE;
LEVOTHYROXINE;
LITHIUM;
NEUROLEPTIC AGENT;
NIMODIPINE;
OLANZAPINE;
OMEGA 3 FATTY ACID;
RISPERIDONE;
THYROID HORMONE;
TOPIRAMATE;
VALPROIC ACID;
VERAPAMIL;
AGRANULOCYTOSIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
ELECTROCONVULSIVE THERAPY;
HUMAN;
MANIA;
MANIC DEPRESSIVE PSYCHOSIS;
PARESTHESIA;
PSYCHOPHARMACOTHERAPY;
PSYCHOSOCIAL CARE;
VERTIGO;
WEIGHT REDUCTION;
ANTICONVULSANTS;
ANTIMANIC AGENTS;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
COMBINED MODALITY THERAPY;
DRUG RESISTANCE;
ELECTROCONVULSIVE THERAPY;
FAMILY THERAPY;
FATTY ACIDS, OMEGA-3;
HUMANS;
PSYCHOTHERAPY;
THYROXINE;
|
EID: 0035099016
PISSN: 00259284
EISSN: None
Source Type: Journal
DOI: 10.1521/bumc.65.1.26.18709 Document Type: Conference Paper |
Times cited : (14)
|
References (45)
|